Tissue factor pathway inhibitor (TFPI) is a vital anticoagulation factor that inhibits factor Xa and factor VIIa to prevent prothrombotic diseases, including coronary artery disease (CAD) [9,10]. This evidence concerns the gene TFPI and coronary artery disorder.